The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.
Elena A KosenkoLyudmila TikhonovaGubidat AlilovaAmparo UriosCarmina MontoliuPublished in: Journal of clinical medicine (2020)
Alzheimer's disease (AD) is a fatal form of dementia of unknown etiology. Although amyloid plaque accumulation in the brain has been the subject of intensive research in disease pathogenesis and anti-amyloid drug development; the continued failures of the clinical trials suggest that amyloids are not a key cause of AD and new approaches to AD investigation and treatment are needed. We propose a new hypothesis of AD development based on metabolic abnormalities in circulating red blood cells (RBCs) that slow down oxygen release from RBCs into brain tissue which in turn leads to hypoxia-induced brain energy crisis; loss of neurons; and progressive atrophy preceding cognitive dysfunction. This review summarizes current evidence for the erythrocytic hypothesis of AD development and provides new insights into the causes of neurodegeneration offering an innovative way to diagnose and treat this systemic disease.
Keyphrases
- resting state
- white matter
- clinical trial
- public health
- functional connectivity
- mild cognitive impairment
- multiple sclerosis
- cerebral ischemia
- red blood cell
- spinal cord
- randomized controlled trial
- cognitive decline
- coronary artery disease
- late onset
- sensitive detection
- early onset
- open label
- cognitive impairment
- blood brain barrier
- brain injury